Sai Life Sciences IPO
ListedSai Life Sciences IPO Details
-
Bidding Date
11-Dec-2024 to
13-Dec-2024 -
Issue Size
₹3042.62 Cr
-
Price Band
₹522 to ₹549
-
Allotment date
16-Dec-2024
-
Listing date
18-Dec-2024
-
Lot size
27
-
No. of shares
5,54,21,123
-
Fresh issue/OFS
₹950 Cr/₹2092.62 Cr
About Sai Life Sciences Company
Established in 1999, Sai Life Sciences Ltd operates as a CRDMO offering integrated services across the pharmaceutical value chain. It specializes in two primary areas: (1) Contract Research (CRO) and (2) Contract Development and Manufacturing (CDMO). In CRO, it provides end-to-end discovery services, including target identification, hit identification, biological assay development, medicinal chemistry, synthetic chemistry, and drug metabolism and pharmacokinetics (DMPK). In CDMO, the company focuses on the development, scaling, and manufacturing of active pharmaceutical ingredients (APIs) and intermediates, supporting both clinical and commercial supplies. The company also operates across multiple therapeutic areas, such as oncology, CNS disorders, inflammation, antivirals, and rare diseases.
Read our in-depth analysis of the Sai Life Sciences Ltd IPO Here
Subscription Status
-
Category
Status
-
QIBs
30.9x
-
NIIs
4.9x
-
Retail
1.4x
-
Others
--
-
Total
10.3x
FAQs for Sai Life Sciences IPO.
What is the issue size of Sai Life Sciences IPO?
The issue size of Sai Life Sciences is ₹3,042.62 Cr.
What is the industry of Sai Life Sciences?
Sai Life Sciences falls into Biotechnology & R&D industry.
Where Sai Life Sciences IPO will be listed?
The Sai Life Sciences IPO will be listed on both NSE and BSE.
What are the open and close dates for the Sai Life Sciences IPO?
The open and close dates for the Sai Life Sciences are 11-Dec-2024 & 13-Dec-2024.
What are the price band for Sai Life Sciences IPO?
The price band for the Sai Life Sciences ipo is ₹522 to ₹549
What is the listing date of Sai Life Sciences IPO?
The listing date of Sai Life Sciences IPO is 18-Dec-2024.
What is the purpose for the Sai Life Sciences IPO?
The purpose of this IPO is to raise fresh capital as well as enable the existing shareholders to sell their stake.
How much times Sai Life Sciences IPO subscribed?
Sai Life Sciences total subscription ratio is 10.3X.
What are the key financials for the Sai Life Sciences IPO?
Key financial of the Sai Life Sciences are:
| Sai Life Sciences | FY-24 | FY-23 | FY-22 |
|---|---|---|---|
| Revenue (₹ Cr) | 1465.18 | 1217.14 | 869.59 |
| EBIT (₹ Cr) | 167.7 | 69.47 | 34.73 |
| Proft after Tax (₹ Cr) | 82.81 | 9.99 | 6.23 |
| Debt (₹ Cr) | 710.16 | 699.23 | 751.32 |
| Net Worth (₹ Cr) | 975.14 | 888.09 | 878.57 |
| RoE (%) | 8.49 | 1.12 | 0.71 |